Fineline Cube

Follow:
14409 Articles
Henlius Pharmaceutical Initiates Phase III Study for HLX22 in Gastric Cancer Treatment
CompanyDrug

Henlius Biotech Initiates Phase III Study for HLX22 in Gastric Cancer Treatment

China's NHC Sets Sights on Enhancing Grassroots Drug Management and Access
Policy / Regulatory

China’s NHC Sets Sights on Enhancing Grassroots Drug Management and Access

MicroPort Scientific Corp.'s BonaFire Receives NMPA Approval as First Whole-Body MRI Safety Pacing Electrode Lead
CompanyDrug

MicroPort Scientific Corp.’s BonaFire Receives NMPA Approval as First Whole-Body MRI Safety Pacing Electrode Lead

Base Therapeutics' NK510 Receives US FDA Clearance for Advanced Solid Tumor Studies
CompanyDrug

Base Therapeutics’ NK510 Receives US FDA Clearance for Advanced Solid Tumor Studies

Merck KGaA Partners with NTU Singapore to Drive Digital Transformation with Trust Technology
CompanyDeals

Merck KGaA Partners with NTU Singapore to Drive Digital Transformation with Trust Technology

GSK's Arexvy Receives MHLW Approval for Expanded RSV Indication in Japan
CompanyDrug

GSK’s Arexvy Receives MHLW Approval for Expanded RSV Indication in Japan

China Resources Double-Crane Gets NMPA Approval for Semaglutide Biosimilar Clinical Trial
CompanyDrug

China Resources Double-Crane Gets NMPA Approval for Semaglutide Biosimilar Clinical Trial

J&J Submits sBLA to FDA for Subcutaneous Tremfya Regimen in Ulcerative Colitis
CompanyDrug

J&J Submits sBLA to FDA for Subcutaneous Tremfya Regimen in Ulcerative Colitis

Servier’s Vorasidenib Approved in Boao Lecheng Medical Zone for Diffuse Gliomas
CompanyDrug

Servier’s Vorasidenib Approved in Boao Lecheng Medical Zone for Diffuse Gliomas

Leads Biolabs' LBL-024 Earns FDA Orphan Drug Designation for Neuroendocrine Cancer
CompanyDrug

Leads Biolabs’ LBL-024 Earns FDA Orphan Drug Designation for Neuroendocrine Cancer

Signet Therapeutics' SIGX1094 Earns Orphan Drug Designation for Gastric Cancer from FDA
CompanyDrug

Signet Therapeutics’ SIGX1094 Earns Orphan Drug Designation for Gastric Cancer from FDA

Hanx Biopharmaceuticals Files for IPO on Hong Kong Stock Exchange
CompanyDeals

Hanx Biopharmaceuticals Files for IPO on Hong Kong Stock Exchange